Author:
Vogelhuber M.,Hart C.,Grube M.,Reichle A.
Reference36 articles.
1. Kumari A, Brendel C, Hochhaus A, Neubauer A, Burchert A (2012) Low BCR-ABL Expression levels in hematopoietic precursor cells enable persistence of chronic myeloid leukemia under imatinib. Blood 119(2):530–539
2. Joensuu H (2012) Adjuvant treatment of GIST: patient selection and treatment strategies. Nat Rev Clin Oncol 9(6):351–358
3. Michallet AS, Lebras L, Coiffier B (2012) Maintenance therapy in diffuse large B-cell lymphoma. Curr Opin Oncol (Epub ahead of print)
4. Untch M, Fasching PA, Konecny GE et al (2011) Pathologic complete response after neoadjuvant chemotherapy plus trastuzumab predicts favorable survival in human epidermal growth factor receptor 2-overexpressing breast cancer results from the TECHNO trial of the AGO and GBG study groups. J Clin Oncol 29(25):3351–3357
5. Palumbo A, Hajek R, Delforge M et al (2012) MM-015 Investigators. Continuous lenalidomide treatment for newly diagnosed multiple myeloma N Engl J Med 366(19):1759–1769 Erratum in: N Engl J Med 367(3):285